Skip to main content

Margaret Johnson

Associate Professor of Neurosurgery
Neurosurgery
047 Baker House, Trent Drive, Box 3624, Durham, NC 27710
047 Baker House, Trent Drive, Box 3624, Durham, NC 27710

Overview


I am a neuro-oncologist, neurologist, and palliative care physician at the Preston Robert Tisch Brain Tumor Center. I also provide neuro-oncology expertise for the National Tele-Oncology Program and National Precision Oncology Program at the Veteran's Health Administration. My clinical and research interests encompass supportive care and palliative care with a special interest in older adults with brain tumors. The incidence of malignant brain tumors like glioblastoma and non-malignant tumors like meningioma affect aging populations and it is crucial to be able to provide better care for these patients.

Current Appointments & Affiliations


Associate Professor of Neurosurgery · 2025 - Present Neurosurgery, Neurosurgery
Associate Professor in Neurology · 2025 - Present Neurology, General & Community Neurology, Neurology
Member of the Duke Cancer Institute · 2018 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Associations Between Problem List Items and Clinically Significant Distress in Patients with Metastatic Spine Disease.

Journal Article Spine (Phila Pa 1976) · March 25, 2025 STUDY DESIGN: Retrospective cohort study. OBJECTIVE: This study aimed to identify sources of distress in patients with metastatic spine disease and elucidate factors associated with clinically significant distress. SUMMARY OF BACKGROUND DATA: Distress is a ... Full text Link to item Cite

Perioperative Trends in Distress Among Cancer Patients: A Systematic Review and Meta-Analysis.

Journal Article Cancer Med · March 2025 INTRODUCTION: Distress is common among cancer patients, especially those undergoing surgery. However, no study has systematically analyzed distress trends in this population. The purpose of this study was to systematically review perioperative rates of dis ... Full text Link to item Cite

Financial toxicity of oral chemotherapy in patients with primary brain tumors.

Journal Article Neuro-oncology practice · February 2025 BackgroundCancer treatment costs continue to rise with the development of new agents. Financial toxicity is defined as the quantifiable costs associated with cancer and cancer treatment in addition to the patient's associated distress. This study' ... Full text Cite
View All Publications

Education, Training & Certifications


Tulane University, School of Medicine · 2011 M.D.
The George Washington University · 2006 M.P.H.
Northwestern University · 2001 B.A.